{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:52:32Z","timestamp":1791478352915,"version":"4.3.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.htct.2026.106463","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:30:29Z","timestamp":1778765429000},"page":"106463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Demographic and prognostic factors affecting survival in acute myelomonocytic leukemia with abnormal eosinophils"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6403-502X","authenticated-orcid":false,"given":"Beau","family":"Hsia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5403-0916","authenticated-orcid":false,"given":"Jasika","family":"Grover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2774-9780","authenticated-orcid":false,"given":"Mahadevan","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2094-0512","authenticated-orcid":false,"given":"Assal","family":"Sadighian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7847-5995","authenticated-orcid":false,"given":"Anton","family":"Sachs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhanu","family":"Upadhyayula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4843-4639","authenticated-orcid":false,"given":"Timothy J.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.htct.2026.106463_bib0001","unstructured":"National Cancer Institute. Acute Myeloid Leukemia Treatment (PDQ\u00ae)\u2013Patient Version. Updated February 7, 2025. Accessed April 3, 2025. https:\/\/www.cancer.gov\/types\/leukemia\/patient\/adult-aml-treatment-pdq"},{"key":"10.1016\/j.htct.2026.106463_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.lrr.2020.100209","article-title":"New translocation in acute myeloid leukemia M4 eos","volume":"14","author":"Bahoush","year":"2020","journal-title":"Leukemia Research Reports"},{"key":"10.1016\/j.htct.2026.106463_bib0003","unstructured":"National Cancer Institute. SEER Hematopoietic and Lymphoid Neoplasm Database. National Cancer Institute; 2025. Accessed April 3, 2025. https:\/\/seer.cancer.gov\/seertools\/hemelymph\/51f6cf58e3e27c3994bd53e7\/"},{"key":"10.1016\/j.htct.2026.106463_bib0004","unstructured":"American Cancer Society. Surgery for Acute Myeloid Leukemia (AML). American Cancer Society; 2025. Accessed April 3, 2025. https:\/\/www.cancer.org\/cancer\/types\/acute-myeloid-leukemia\/treating\/surgery.html"},{"key":"10.1016\/j.htct.2026.106463_bib0005","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3324\/haematol.11889","article-title":"M4 acute myeloid leukemia: the role of eosinophilia and cytogenetics in treatment response and survival. The GIMEMA experience","volume":"93","author":"Pulsoni","year":"2008","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.htct.2026.106463_bib0006","article-title":"Prognostics and clinical outcomes in patients diagnosed with acute myeloid leukemia (AML) in a teaching hospital","volume":"13","author":"Alsulami","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.htct.2026.106463_bib0007","doi-asserted-by":"crossref","first-page":"876","DOI":"10.3390\/jcm13030876","article-title":"Approach to acute myeloid leukemia with increased eosinophils and basophils","volume":"13","author":"Papadakis","year":"2024","journal-title":"JCM"},{"key":"10.1016\/j.htct.2026.106463_bib0008","doi-asserted-by":"crossref","first-page":"S316","DOI":"10.1016\/j.healun.2020.01.713","article-title":"Charlson-Deyo-comorbidity-index predicts long-term survival in lung transplantation","volume":"39","author":"Ehrsam","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.htct.2026.106463_bib0009","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.1038\/s41598-024-55432-8","article-title":"Epidemiology and prognostic nomogram for chronic eosinophilic leukemia: a population-based study using the SEER database","volume":"14","author":"Wang","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.htct.2026.106463_bib0010","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3390\/cancers16020337","article-title":"Hematological neoplasms with eosinophilia","volume":"16","author":"Morales-Camacho","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.htct.2026.106463_bib0011","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/ajh.23515","article-title":"Eosinophilia in routine blood samples and the subsequent risk of hematological malignancies and death","volume":"88","author":"Andersen","year":"2013","journal-title":"American J Hematol"},{"key":"10.1016\/j.htct.2026.106463_bib0012","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1182\/blood.V87.6.2459.bloodjournal8762459","volume":"87","author":"Haferlach","year":"1996","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.htct.2026.106463_bib0013","first-page":"494","article-title":"IDH1 Inhibitor for the treatment of acute myeloid leukemia","volume":"10","author":"Merchant","year":"2019","journal-title":"J Adv Pract Oncol"},{"key":"10.1016\/j.htct.2026.106463_bib0014","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.3324\/haematol.2022.281045","article-title":"Daunorubicin-60 versus daunorubicin-90 versus idarubicin-12 for induction chemotherapy in acute myeloid leukemia: a retrospective analysis of the Mayo Clinic experience","volume":"107","author":"Tefferi","year":"2022","journal-title":"Haematol"},{"key":"10.1016\/j.htct.2026.106463_bib0015","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/SLA.0000000000002095","article-title":"The effect of hospital volume on breast cancer mortality","volume":"267","author":"Greenup","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.htct.2026.106463_bib0016","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/01.sla.0000098616.19622.af","article-title":"Ihse I: the volume-outcome relationship in cancer surgery: a hard sell","volume":"238","year":"2003","journal-title":"Ann Surg"},{"key":"10.1016\/j.htct.2026.106463_bib0017","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3390\/biomedicines11020641","article-title":"Targeted therapy development in acute myeloid leukemia","volume":"11","author":"Totiger","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.htct.2026.106463_bib0018","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.1112","article-title":"Socioeconomic status and overall survival among patients with hematological malignant neoplasms","volume":"7","author":"Nielsen","year":"2024","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.htct.2026.106463_bib0019","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1200\/JCO.2017.73.6728","article-title":"Effects of education and income on treatment and outcome in patients with acute myeloid leukemia in a tax-supported health care system: a national population-based cohort study","volume":"35","author":"\u00d8stg\u00e5rd","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.htct.2026.106463_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.659595","article-title":"Allogeneic stem cell transplantation for acute myeloid leukemia: who, when, and how?","volume":"12","author":"Loke","year":"2021","journal-title":"Front Immunol"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137926002105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137926002105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:04:11Z","timestamp":1791475451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137926002105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2531137926002105"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2026.106463","relation":{},"ISSN":["2531-1379"],"issn-type":[{"value":"2531-1379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Demographic and prognostic factors affecting survival in acute myelomonocytic leukemia with abnormal eosinophils","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2026.106463","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"106463"}}